// App-Quantinova.ai

B28-01 : A COMBINATORIAL TREATMENT STRATEGY FOR REDUCING ASTROCYTE REACTIVITY USING NEURAL PROGENITOR CELLS AND HEPATOCYTE GROWTH FACTOR

Researchers

Presenter

  • Dragas Rachel

Principal Investigators

  • Hong James

Medical Centers

  • Siddiqui Ahad, Fehlings Michael

  • Krembil Research Institute, Toronto Western Hospital, Genetics and Development, Toronto, Canada

  • University of Toronto, Institute of Medical Science, Toronto, Canada

  • University of Toronto, Department of Neurosurgery, Toronto, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • Glial fibrillary acidic protein

  • Hepatocyte growth factor

  • TIMP Metallopeptidase Inhibitor 1

  • Vimentin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved